| Identifiers | |
|---|---|
| |
| CAS Number | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.229.843 |
| Chemical and physical data | |
| Formula | C13H18Cl2N2 |
| Molar mass | 273.20 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
BD1063 or1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine is a selectivesigma receptorantagonist, with a reportedbinding affinity ofKi = 9 ± 1 nM for thesigma-1 receptor and more than 49 times selectivity over thesigma-2 receptor.[1]
Consistent with other reportedsigma receptorantagonists, pretreating Swiss Webster mice with BD1063 significantly decreases the convulsivity and lethality of cocaine.[1]
In other animal studies, BD1063 blocks the effects ofMDMA,[2] and reduces alcohol intake in rodent models ofalcoholism.[3]